Skip to search formSkip to main contentSkip to account menu

alizapride

Known as: N-((1-Allyl-2-Pyrrolidinyl)Methyl)-6-Methoxy-1H-Benzotriazole-5-Carboxamide, Alizaprida, Alizapridum 
A substituted benzamide that acts as a dopamine receptor antagonist with antiemetic properties.
National Institutes of Health

Related topics

Related topics

6 relations

Broader (2)

AntiemeticsPyrrolidines

Narrower (4)

MS 5080PliticanVergentanalizapride hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Adverse Drug Events in Older Hospitalized Patients: Results and Reliability of a Comprehensive and Structured Identification Strategy
Background Older patients are at high risk for experiencing Adverse Drug Events (ADEs) during hospitalization. To be able to… 
Highly Cited
2006
Highly Cited
2006
Study of the prophylactic effect of droperidol, alizapride, propofol and promethazine on spinal morphine-induced pruritus.
BACKGROUND We have compared the use of alizapride, propofol, droperidol and promethazine for the prevention of spinal morphine… 
1996
1996
Determination of unbound etoposide concentration in ultrafiltered plasma by high-performance liquid chromatography with fluorimetric detection.
Highly Cited
1994
Highly Cited
1994
Granisetron
SynopsisGranisetron is a selective serotonin3 (5-hydroxytryptamine3, 5-HT3) receptor antagonist which has significant antiemetic… 
1992
1992
Comparison of three protracted antiemetic regimens for the control of delayed emesis in cisplatin-treated patients.
1991
1991
Tropisetron plus haloperidol to ameliorate nausea and vomiting associated with high-dose alkylating agent cancer chemotherapy.
Highly Cited
1986
Highly Cited
1986
Droperidol, alizapride and metoclopramide in the prevention and treatment of post-operative emetic sequelae.
Women (182) undergoing elective orthopaedic surgery under general anaesthesia received 100 or 200 mg alizapride, 1.25 mg… 
1986
1986
The antiemetic activity of high‐dose alizapride and high‐dose metoclopramide in patients receiving cancer chemotherapy: A prospective, randomized, double‐blind trial
Alizapride is a new substituted benzamide with suggested superior antiemetic efficacy to and fewer side effects than… 
Highly Cited
1986
Highly Cited
1986
The thermodynamics of agonist and antagonist binding to dopamine D-2 receptors.
The ability of dopamine agonists and antagonists to compete with [3H]spiperone binding to rat striatal membrane preparations at 4… 
1985
1985
Comparison of the antiemetic efficacy of two high-dose benzamides, metoclopramide and alizapride, against cisplatin-induced emesis.
The antiemetic effect of two benzamides, metoclopramide (MCL; Paspertin) and alizapride (AZP; Vergentan), was compared in two… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)